National Bank of Canada’s XBiotech XBIT Stock Holding History

National Bank of Canada’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.5K	Hold	25,000	–	–	﹤0.01%	1996
2026 Q1	$58.8K	Hold	25,000	–	–	﹤0.01%	1932
2025 Q4	$58.8K	Hold	25,000	–	–	﹤0.01%	1933
2025 Q3	$66K	Hold	25,000	–	–	﹤0.01%	1863
2025 Q2	$74K	Hold	25,000	–	–	﹤0.01%	1866
2025 Q1	$80.3K	Hold	25,000	–	–	﹤0.01%	1755
2024 Q4	$98.8K	Sell	25,000 -8,000	-24%	-$54.5K	﹤0.01%	1763
2024 Q3	$255K	Hold	33,000	–	–	﹤0.01%	1335
2024 Q2	$182K	Hold	33,000	–	–	﹤0.01%	1364
2024 Q1	$272K	Buy	33,000 +8,653	+36%	+$49.6K	﹤0.01%	1369
2023 Q4	$103K	Buy	+24,347	New	+$97K	﹤0.01%	1570

Other funds holding XBIT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

National Bank of Canada's XBIT Position: Q2 2026 in Review

National Bank of Canada held its XBiotech (XBIT) position steady in Q2 2026 at 25,000 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

National Bank of Canada first reported a position in XBIT in Q4 2023 and has held it in 11 quarters since. The position peaked at $272K in Q1 2024. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

National Bank of Canada held 25,000 shares of XBiotech worth $57.5K as of Q2 2026.
National Bank of Canada left its XBiotech share count unchanged in Q2 2026.
XBiotech made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #1996 holding.
National Bank of Canada first reported a position in XBiotech in Q4 2023 and has held it in 11 quarters since.
National Bank of Canada's XBiotech position peaked at $272K in Q1 2024.
36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.